Interestingly, analysis of the independent human colorectal cancer cohort from TCGA (The Cancer Genome Atlas) database demonstrated that patients with higher level of Bcl6 (in Foxp3+CD4+ cells) showed significantly poorer overall survival compared to those with a lower level (Figure 5A). This evidence concerns the gene BCL6 and colorectal cancer.